Showing results (1-10 of 325) with videos related to
Sort By:
Pageof 33
Blood|October 23, 2008
T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapyRoch Houot, Ronald LevyBlood Reviews|October 28, 2008
Vaccines for lymphomas: idiotype vaccines and beyondRoch Houot, Ronald LevyEuropean Journal of Cancer (Oxford, England : 1990)|July 4, 2020
Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?Roch Houot, Ronald Levy, Guillaume Cartron, et al.Cancer Metastasis Reviews|January 29, 2011
Immunomodulating antibodies and drugs for the treatment of hematological malignanciesRoch Houot, Holbrook Kohrt, Matthew J Goldstein, et al.Trends in Immunology|September 13, 2011
Targeting immune effector cells to promote antibody-induced cytotoxicity in cancer immunotherapyRoch Houot, Holbrook E Kohrt, Aurélien Marabelle, et al.Cancer Research|January 11, 2012
Adoptive cell therapy for lymphoma with CD4 T cells depleted of CD137-expressing regulatory T cellsMatthew J Goldstein, Holbrook E Kohrt, Roch Houot, et al.Bulletin Du Cancer|December 18, 2021
[CAR-T cells in lymphomas: Current and evolving role]Ondine Messéant, Roch HouotClinical Case Reports|June 8, 2017
"Chronic myelogenous leukemia in primary blast crisis" rather than "de novo <i>BCR-ABL1</i>-positive acute myeloid leukemia"Cedric Pastoret, Roch HouotOncoimmunology|January 23, 2015
CD137 stimulation enhances the vaccinal effect of anti-tumor antibodiesRoch Houot, Holbrook KohrtImmunotherapy|May 31, 2012
Combination strategies to enhance antitumor ADCCHolbrook E Kohrt, Roch Houot, Aurélien Marabelle, et al.Pageof 33